虚血性脳卒中手術市場は、2035 年までに 72 億 6000 万ドルに達し、2022 年から 2035 年までに8.70% の CAGR で拡大すると予想されます。虚血性脳卒中は、血栓が脳につながる動脈を塞いだり狭めたりするときに発生します。血栓の多くは、プラークの蓄積(アテローム性動脈硬化)によって損傷した動脈に形成されます。首の頸動脈だけでなく、他の動脈にも発生する可能性があります。これは、最も一般的なタイプの脳卒中です。
	世界中誰にでも起こり得る脳卒中の形態としては、一過性脳虚血発作、出血性脳卒中、虚血性脳卒中の3つがあります。世界の虚血性脳卒中手術市場をけん引する要因には、運動不足や座りがちなライフスタイルの増加、技術的に高度な製品の採用と発売、低侵襲手術に対する需要の高まりなどがあります。さらに、研究開発活動と投資が、予測期間中、市場プレーヤーに有利な成長機会を生み出すことが期待されます。一方で、発展途上国における医療施設の不備と熟練した専門家の不足によって、予測期間中の市場の成長が抑制されます。
								
						目次
						
	TABLE OF CONTENTS
	1 EXECUTIVE SUMMARY
	
	1.1 OVERVIEW
	2 MARKET INTRODUCTION
	
	2.1 DEFINITION
	2.2 SCOPE OF THE STUDY
	2.3 RESEARCH OBJECTIVE
	2.4 MARKET STRUCTURE
	2.5 ASSUMPTIONS & LIMITATIONS
	3 RESEARCH METHODOLOGY
	
	3.1 DATA MINING
	3.2 SECONDARY RESEARCH
	3.3 PRIMARY RESEARCH
	3.4 BREAKDOWN OF PRIMARY RESPONDENTS
	3.5 FORECASTING TECHNIQUES
	3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
	3.6.1 BOTTOM-UP APPROACH
	3.6.2 TOP-DOWN APPROACH
	3.7 DATA TRIANGULATION
	3.8 VALIDATION
	4 MARKET DYNAMICS
	
	4.1 OVERVIEW
	4.2 DRIVERS
	4.2.1 RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
	4.2.2 ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
	4.2.3 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
	4.3 RESTRAINTS
	4.3.1 LACK OF MEDICAL FACILITIES
	4.3.2 SHORTAGE OF SKILLED PROFESSIONALS
	4.4 OPPORTUNITIES
	4.4.1 R&D ACTIVITIES AND INVESTMENTS
	5 MARKET FACTOR ANALYSIS
	
	5.1 VALUE CHAIN ANALYSIS
	5.1.1 R&D
	5.1.2 MANUFACTURING
	5.1.3 DISTRIBUTION AND SALES
	5.1.4 POST-SALES MONITORING
	5.2 PORTER’S FIVE FORCES MODEL
	5.2.1 THREAT OF NEW ENTRANTS
	5.2.2 BARGAINING POWER OF SUPPLIERS
	5.2.3 THREAT OF SUBSTITUTES
	5.2.4 BARGAINING POWER OF BUYERS
	5.2.5 INTENSITY OF RIVALRY
	5.3 IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
	5.3.1 IMPACT ON SUPPLY CHAIN
	5.3.2 IMPACT ON PRODUCTION
	5.3.3 IMPACT ON DEMAND
	5.4 EPIDEMIOLOGY ANALYSIS
	5.4.1 INCIDENCE & PREVALENCE
	5.4.2 NUMBER OF PROCEDURES FOR THROMBECTOMY
	5.5 REGULATORY ANALYSIS/HEALTHCARE SYSTEM
	6 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY
	
	6.1 OVERVIEW
	6.2 THROMBECTOMY
	6.3 REVASCULARIZATION SURGERY
	6.4 CAROTID ENDARTERECTOMY
	6.5 ANGIOPLASTY
	6.6 OTHERS
	7 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE
	
	7.1 OVERVIEW
	7.2 CATHETER
	7.3 ASPIRATION SYSTEM
	7.4 GUIDEWIRE
	7.5 MICROCATHETER
	7.6 OTHERS
	8 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER
	
	8.1 OVERVIEW
	8.2 HOSPITALS AND CLINICS
	8.3 AMBUATORY SURGICAL CENTRES
	8.4 OTHERS
	9 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION
	
	9.1 OVERVIEW
	9.2 NORTH AMERICA
	9.2.1 US
	9.2.2 CANADA
	9.3 EUROPE
	9.3.1 GERMANY
	9.3.2 UK
	9.3.3 FRANCE
	9.3.4 ITALY
	9.3.5 SPAIN
	9.3.6 REST OF EUROPE
	9.4 ASIA PACIFIC
	9.4.1 JAPAN
	9.4.2 CHINA
	9.4.3 INDIA
	9.4.4 AUSTRALIA
	9.4.5 SOUTH KOREA
	9.4.6 REST OF ASIA PACIFIC
	9.5 REST OF THE WORLD
	9.5.1 MIDDLE EAST
	9.5.2 AFRICA
	9.5.3 LATIN AMERICA
	10 COMPETITIVE LANDSCAPE
	
	10.1 OVERVIEW
	10.2 MARKET SHARE ANAYISIS
	10.3 COMPETITIVE BENCHMARKING
	10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
	10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
	10.6 KEY DEVELOPMENT ANALYSIS
	10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
	10.7.1 MERGER & ACQUISITIONS
	10.7.2 AGREEMENT/MARKETING STRATEGIES
	10.8 FINANCIAL MATRIX
	10.8.1 SALES (USD MILLION), 2021
	10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021
	11 COMPANY PROFILES
	
	11.1 MEDTRONIC PLC
	11.1.1 COMPANY OVERVIEW
	11.1.2 FINANCIAL OVERVIEW
	11.1.3 PRODUCTS OFFERED
	11.1.4 KEY DEVELOPMENTS
	11.1.5 SWOT ANALYSIS
	11.1.6 KEY STRATEGIES
	11.2 ABBOTT LABORATORIES
	11.2.1 COMPANY OVERVIEW
	11.2.2 FINANCIAL OVERVIEW
	11.2.3 PRODUCTS OFFERED
	11.2.4 KEY DEVELOPMENTS
	11.2.5 KEY STRATEGIES
	11.3 BOSTON SCIENTIFIC CORPORATION
	11.3.1 COMPANY OVERVIEW
	11.3.2 FINANCIAL OVERVIEW
	11.3.3 PRODUCTS OFFERED
	11.3.4 KEY DEVELOPMENTS
	11.3.5 KEY STRATEGIES
	11.4 CORDIS CORPORATION
	11.4.1 COMPANY OVERVIEW
	11.4.2 FINANCIAL OVERVIEW
	11.4.3 PRODUCTS OFFERED
	11.4.4 KEY DEVELOPMENTS
	11.4.5 KEY STRATEGIES
	11.5 KONINKLIJKE PHILIPS N.V
	11.5.1 COMPANY OVERVIEW
	11.5.2 FINANCIAL OVERVIEW
	11.5.3 PRODUCTS OFFERED
	11.5.4 KEY DEVELOPMENTS
	11.5.5 SWOT ANALYSIS
	11.5.6 KEY STRATEGIES
	11.6 STRYKER
	11.6.1 COMPANY OVERVIEW
	11.6.2 FINANCIAL OVERVIEW
	11.6.3 PRODUCTS OFFERED
	11.6.4 KEY DEVELOPMENTS
	11.6.5 SWOT ANALYSIS
	11.6.6 KEY STRATEGIES
	11.7 IMPERATIVE CARE
	11.7.1 COMPANY OVERVIEW
	11.7.2 FINANCIAL OVERVIEW
	11.7.3 PRODUCTS OFFERED
	11.7.4 KEY DEVELOPMENTS
	11.7.5 KEY STRATEGIES
	11.8 JOHNSON & JOHNSON SERVICES, INC.
	11.8.1 COMPANY OVERVIEWS
	11.8.2 FINANCIAL OVERVIEW
	11.8.3 PRODUCTS OFFERED
	11.8.4 KEY DEVELOPMENTS
	11.8.5 SWOT ANALYSIS
	11.8.6 KEY STRATEGIES
	11.9 PENUMBRA, INC.
	11.9.1 COMPANY OVERVIEW
	11.9.2 FINANCIAL OVERVIEW
	11.9.3 PRODUCTS OFFERED
	11.9.4 KEY DEVELOPMENTS
	11.9.5 SWOT ANALYSIS
	11.9.6 KEY STRATEGIES
	11.10 PHENOXYHENOX GMBH
	11.10.1 COMPANY OVERVIEW
	11.10.2 FINANCIAL OVERVIEW
	11.10.3 PRODUCTS OFFERED
	11.10.4 KEY DEVELOPMENTS
	11.10.5 KEY STRATEGIES
	12 APPENDIX
	
	12.1 REFERENCES
	12.2 RELATED REPORTS
	?
	LIST OF TABLES
	
	TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
	TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
	TABLE 3 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
	TABLE 4 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY COUNTRY (2021)
	TABLE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 6 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR THROMBECTOMY, BY REGION, 2018-2035 (USD MILLION)
	TABLE 7 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR REVASCULARIZATION SURGERY, BY REGION, 2018-2035 (USD MILLION)
	TABLE 8 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018-2035 (USD MILLION)
	TABLE 9 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018-2035 (USD MILLION)
	TABLE 10 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
	TABLE 11 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 12 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018-2035 (USD MILLION)
	TABLE 13 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018-2035 (USD MILLION)
	TABLE 14 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018-2035 (USD MILLION)
	TABLE 15 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018-2035 (USD MILLION)
	TABLE 16 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
	TABLE 17 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 18 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2035 (USD MILLION)
	TABLE 19 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018-2035 (USD MILLION)
	TABLE 20 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018-2035 (USD MILLION)
	TABLE 21 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035 (USD MILLION)
	TABLE 22 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
	TABLE 23 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 24 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 25 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 26 US: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 27 US: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 28 US: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 29 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 30 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 31 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 32 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
	TABLE 33 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 34 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 35 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 36 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 37 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 38 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 39 UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 40 UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 41 UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 42 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 43 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 44 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 45 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 46 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 47 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 48 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 49 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 50 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 51 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 52 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 53 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 54 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
	TABLE 55 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 56 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 57 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 58 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 59 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 60 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 61 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 62 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 63 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 64 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 65 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 66 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 67 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 68 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 69 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 70 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 71 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 72 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 73 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 74 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 75 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 76 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035(USD MILLION)
	TABLE 77 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 78 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 79 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 80 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 81 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 82 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 83 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 84 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 85 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 86 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
	TABLE 87 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
	TABLE 88 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
	TABLE 89 MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
	TABLE 90 MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
	TABLE 91 PRODUCT LAUNCH/PRODUCT APPROVAL
	TABLE 92 MERGER & ACQUISITIONS
	TABLE 93 AGREEMENT/MARKETING STRATEGIES
	TABLE 94 MEDTRONIC PLC: PRODUCTS OFFERED
	TABLE 95 ABBOTT LABORATORIES: PRODUCTS OFFERED
	TABLE 96 ABBOTT LABORATORIES: KEY DEVELOPMENTS
	TABLE 97 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
	TABLE 98 CORDIS CORPORATION: PRODUCTS OFFERED
	TABLE 99 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
	TABLE 100 STRYKER: PRODUCTS OFFERED
	TABLE 101 STRYKER: KEY DEVELOPMENTS
	TABLE 102 IMPERATIVE CARE: PRODUCTS OFFERED
	TABLE 103 IMPERATIVE CARE: KEY DEVELOPMENTS
	TABLE 104 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
	TABLE 105 JOHNSON & JOHNSON SERVICES, INC.: KEY DEVELOPMENTS
	TABLE 106 PENUMBRA, INC.: PRODUCTS OFFERED
	TABLE 107 PENUMBRA, INC.: KEY DEVELOPMENTS
	TABLE 108 PHENOX GMBH: PRODUCTS OFFERED
	TABLE 109 PHENOX GMBH: KEY DEVELOPMENTS
	?
	LIST OF FIGURES
	
	FIGURE 1 MARKET SYNOPSIS
	FIGURE 2 GLOBAL ISCHEMIC STROKE SURGERY MARKET
	FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
	FIGURE 4 MARKET DYNAMICS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
	FIGURE 5 DRIVERS: IMPACT ANALYSIS
	FIGURE 6 RESTRAINT: IMPACT ANALYSIS
	FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
	FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ISCHEMIC STROKE MARKET
	FIGURE 1 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2021 & 2035 (USD MILLION)
	FIGURE 2 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2021 & 2035 (USD MILLION)
	FIGURE 3 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2021 & 2035 (USD MILLION)
	FIGURE 4 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION 2021 & 2035 (USD MILLION)
	FIGURE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION, 2021
	FIGURE 6 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY 2021
	FIGURE 7 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
	FIGURE 8 EUROPE: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY 2021
	FIGURE 9 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
	FIGURE 10 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY, 2021
	FIGURE 11 ASIA PACIFIC ISCHEMIC STROKE SURGERY MARKET SHARE, BY COUNTRY 2021 & 2035 (USD MILLION)
	FIGURE 12 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION, 2021
	FIGURE 13 REST OF THE WORLD ISCHEMIC STROKE SURGERY MARKET SHARE, BY REGION 2021 & 2035 (USD MILLION)
	FIGURE 14 MAJOR MANUFACTURERS MARKET SHARE (%) ANALYSIS, 2021
	FIGURE 15 BENCHMARKING OF MAJOR COMPETITORS
	FIGURE 16 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
	FIGURE 17 GLOBAL ISCHEMIC STROKE SURGERY MARKET: COMPETITIVE LANDSCAPE
	FIGURE 18 SALES (USD MILLION), 2021
	FIGURE 19 RESEARCH & DEVELOPMENT EXPENDITURE 2021
	FIGURE 20 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 21 MEDTRONIC PLC: SWOT ANALYSIS
	FIGURE 22 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 23 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 24 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 25 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
	FIGURE 26 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 27 STRYKER: SWOT ANALYSIS
	FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 29 JOHNSON & JOHNSON SERVICES INC.: SWOT ANALYSIS
	FIGURE 30 PENUMBRA, INC.: FINANCIAL OVERVIEW SNAPSHOT
	FIGURE 31 PENUMBRA, INC.: SWOT ANALYSIS